G13
For Nasdaq x-listing, I expect yacov to:
1.Issue 16m to 20m news shares to Nasdaq investors, at abt 80c to $1 each;
bringing total SOI to under 400m,
as long as yacov still control 50.1%.
2.Raise U$15 to $20m
3.Acquire a new IDTF, at $6m-10m
4. Ann a few more Purchase Orders
In future, 3-6 months down the track, they can always issue more shares at much higher sp if they need more funds for working capital or more acqua.
*Hygea U$22m POs demo to us that Gmv's Primza & GMPatch are superior to medtech devices of listed or unlisted IRTC or BEAT or 10 other competitors in usa .
(Lets hope LTHs can see this fact)
USA world of 100m 'insured lives' is our little oyster.
cheers,qed,aimo,dyor
.
- Forums
- ASX - By Stock
- GMV
- Ann: Suspension from Official Quotation
Ann: Suspension from Official Quotation, page-139
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online